Results 301 to 310 of about 674,291 (325)
Utility of Clustering in Mortality Risk Stratification in Pulmonary Hypertension. [PDF]
Bioengineering (Basel)Tondo P +9 more
europepmc +1 more source
Mortality Risk Factors and Survival Outcomes in Infants with Persistent Pulmonary Hypertension of the Newborn. [PDF]
J Clin MedChuaikaew K +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs of Today, 1998
Pulmonary hypertension can be caused by an increase in pulmonary blood flow, an increase in left-heart impedance or an increase in pulmonary vascular resistance. Although there are many specific causes that have been identified, clinical presentation and natural history are common to all etiologies.
D, Moraes, J, Loscalzo
openaire +2 more sources
Pulmonary hypertension can be caused by an increase in pulmonary blood flow, an increase in left-heart impedance or an increase in pulmonary vascular resistance. Although there are many specific causes that have been identified, clinical presentation and natural history are common to all etiologies.
D, Moraes, J, Loscalzo
openaire +2 more sources
Nursing Standard, 2002
Pulmonary hypertension (PH) is a rare blood vessel disorder of the lung, in which the pressure in the pulmonary artery rises above normal levels and can become life-threatening. The authors discuss the disease process, symptoms, investigations and patient management.
Paula, Rogers, Iain, Armstrong
openaire +2 more sources
Pulmonary hypertension (PH) is a rare blood vessel disorder of the lung, in which the pressure in the pulmonary artery rises above normal levels and can become life-threatening. The authors discuss the disease process, symptoms, investigations and patient management.
Paula, Rogers, Iain, Armstrong
openaire +2 more sources
Medical Clinics of North America, 2019
Pulmonary hypertension (PH) is a chronic and progressive disease that presents like many other lung diseases, often leading to a delay in diagnosis, and therefore a delay in optimal therapy. This article provides a review of PH for internists, covering clinical presentation, diagnostic algorithm, different types of PH, and overview of treatments.
Darlene, Kim, M Patricia, George
openaire +2 more sources
Pulmonary hypertension (PH) is a chronic and progressive disease that presents like many other lung diseases, often leading to a delay in diagnosis, and therefore a delay in optimal therapy. This article provides a review of PH for internists, covering clinical presentation, diagnostic algorithm, different types of PH, and overview of treatments.
Darlene, Kim, M Patricia, George
openaire +2 more sources
American Journal of Kidney Diseases, 2013
Pulmonary arterial hypertension is a rare disease often associated with positive antinuclear antibody and high mortality. Pulmonary hypertension, which rarely is severe, occurs frequently in patients with chronic kidney disease (CKD). The prevalence of pulmonary hypertension ranges from 9%-39% in individuals with stage 5 CKD, 18.8%-68.8% in ...
Danilo Fliser +18 more
openaire +6 more sources
Pulmonary arterial hypertension is a rare disease often associated with positive antinuclear antibody and high mortality. Pulmonary hypertension, which rarely is severe, occurs frequently in patients with chronic kidney disease (CKD). The prevalence of pulmonary hypertension ranges from 9%-39% in individuals with stage 5 CKD, 18.8%-68.8% in ...
Danilo Fliser +18 more
openaire +6 more sources